UI researchers discover delays in ALS diagnoses for rural patients

On this episode of River to River, Jacob Simmering and Andrea Swenson, lead investigator and co-author of a new ALS study published in February, discuss their research. The two reveal findings from the study and what is in store for patients in the future.

Later in the hour: Iowa lawmakers significantly limited the amount of THC in consumable hemp products, and the Justice Department has formally moved to reclassify marijuana as a less dangerous drug. An expert in cannabis research discusses what makes hemp-derived products different and what the anticipated reclassification of marijuana could mean.

Guests:

• Jacob Simmering, Ph.D., Assistant Professor of Internal Medicine, University of Iowa Carver College of Medicine, lead investigator ALS
• Andrea Swenson, clinical professor of neurology, director of the ALS clinic, co-author
• David Gorelick, professor of psychiatry, department of psychiatry and MPRC , University of Maryland School of Medicine, editor-in-chief of the Journal of Cannabis Research